tiprankstipranks
Trending News
More News >
AlzeCure Pharma AB (DE:AC6)
FRANKFURT:AC6
Germany Market
Advertisement

AlzeCure Pharma AB (AC6) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
AlzeCure Pharma AB’s (AC6) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting AlzeCure Pharma AB is a Sell.
AlzeCure Pharma AB’s (AC6) 20-Day exponential moving average is 0.19, while AlzeCure Pharma AB’s (AC6) share price is €0.16, making it a Sell.
AlzeCure Pharma AB’s (AC6) 50-Day exponential moving average is 0.22, while AlzeCure Pharma AB’s (AC6) share price is €0.16, making it a Sell.

AlzeCure Pharma AB (AC6) Pivot Points

Nov 03, 2025, 02:40 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.15
0.15
0.15
0.15
0.15
0.15
0.15
Fibonacci
0.15
0.15
0.15
0.15
0.15
0.15
0.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AlzeCure Pharma AB (AC6) Moving Averages

Nov 03, 2025, 02:40 PM
Period
Simple
Exponential
MA5
0.17Buy
0.17Buy
MA10
0.18Sell
0.18Buy
MA20
0.19Sell
0.19Sell
MA50
0.23Sell
0.22Sell
MA100
0.25Sell
0.23Sell
MA200
0.21Sell
0.19Sell
AlzeCure Pharma AB’s (AC6) 10-Day exponential moving average is 0.18, while AlzeCure Pharma AB’s (AC6) share price is €0.16, making it a Buy.
AlzeCure Pharma AB’s (AC6) 100-Day exponential moving average is 0.23, while AlzeCure Pharma AB’s (AC6) share price is €0.16, making it a Sell.
AlzeCure Pharma AB’s (AC6) stock price is €0.16 and AlzeCure Pharma AB’s (AC6) 50-day simple moving average is 0.23, creating a Sell signal.
AlzeCure Pharma AB’s (AC6) stock price is €0.16 and AlzeCure Pharma AB’s (AC6) 100-day simple moving average is 0.25, creating a Sell signal.
AlzeCure Pharma AB’s (AC6) stock price is €0.16 and AlzeCure Pharma AB’s (AC6) 200-day simple moving average is 0.21, creating a Sell signal.

AlzeCure Pharma AB (AC6) Technical Indicators

Nov 03, 2025, 02:40 PM
Name
Value
Implied Action
RSI (14)
46.87
Neutral
STOCH (9,6)
7.66
Buy
STOCHRSI (14)
7.66
Buy
MACD (12,26)
-0.01
Sell
ADX (14)
29.77
Neutral
Williams %R
-67.90
Buy
CCI (14)
-62.56
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
52.25
Neutral
ROC
-5.26
Sell
AlzeCure Pharma AB’s (AC6) Relative Strength Index (RSI) is 46.87, creating a Neutral signal.
AlzeCure Pharma AB’s (AC6) Trend Strength Indicator (ADX) is 29.77, creating a Neutral signal.
AlzeCure Pharma AB’s (AC6) Commodity Channel Index (CCI) is -62.56, creating a Neutral signal.
AlzeCure Pharma AB’s (AC6) Price Rate of Change (ROC) is -5.26, creating a Sell signal.

FAQ

Is AC6 a Buy, Hold, or Sell?
Based on AC6’s technical indicators, AC6 is a Sell.
    What is AC6’s RSI (14)?
    AC6’s RSI (14) is 46.87, which suggests AC6 is a Neutral.
      What is AC6’s MACD?
      AC6’s MACD is -0.01, which suggests AC6 is a Sell.
        What is AC6’s 5-day moving average?
        AC6’s 5-day moving average is 0.17, which suggests AC6 is a Buy.
          What is AC6’s 20-day moving average?
          AC6 20-day moving average is 0.19, which suggests AC6 is a Sell.
            What is AC6’s 50-day moving average?
            AC6’s 50-day moving average is 0.23, which suggests AC6 is a Sell.
              What is AC6’s 200-day moving average?
              AC6’s 200-day moving average is 0.21, which suggests AC6 is a Sell.
                What is AC6’s Williams % R (14)?
                AC6’s Williams % R (14) is -67.90, which suggests AC6 is a Buy.
                  What is AC6’s CCI (14)?
                  AC6’s CCI (14) is -62.56, which suggests AC6 is a Neutral.
                    What is the share price of AlzeCure Pharma AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis